Related references
Note: Only part of the references are listed.Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.
Daniel J. Diekema et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods
D. J. Diekema et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Pneumocystis jiroveci pneumonia in patients with AIDS in the inner city:: A persistent and deadly opportunistic infection
Ildefonso Tellez et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2008)
Susceptibility testing and molecular classification of Paecilomyces spp.
Maria Victoria Castelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Clinical isolates of Aspergillus species remain fully susceptible to voriconazole in the post-voriconazole era
Jesus Guinea et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Epidemiological cutoffs and cross-resistance to azole drugs in Aspergillus fumigatus
Juan Luis Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Aspergillus section fumigati: Antifungal susceptibility patterns and sequence-based identification
Laura Alcazar-Fuoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The evolution of resistant Candida species in cancer centers - Implications for treatment and prophylaxis
James Riddell et al.
CANCER (2008)
The changing epidemiology of invasive Candidiasis - Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy
Ray Hachem et al.
CANCER (2008)
Cryptococcosis in Solid Organ Transplant Recipients: Current State of the Science
Nina Singh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Molecular epidemiology of candidemia:: Evidence of clusters of smoldering nosocomial infections
Lena Ros Asmundsdottir et al.
CLINICAL INFECTIOUS DISEASES (2008)
Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients:: 1985-2006
Peter D. Walzer et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America
Stanley W. Chapman et al.
CLINICAL INFECTIOUS DISEASES (2008)
Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit
Jennifer K. Chow et al.
CLINICAL INFECTIOUS DISEASES (2008)
Health care-associated infection (HAI): A critical appraisal of the emerging threat - Proceedings of the HAI Summit
Marin H. Kollef et al.
CLINICAL INFECTIOUS DISEASES (2008)
Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with Hematologic malignancy who have zygomycosis
Georgios Chamilos et al.
CLINICAL INFECTIOUS DISEASES (2008)
Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: Biological risk factors for infection according to time after transplantation
Carol Garcia-Vidal et al.
CLINICAL INFECTIOUS DISEASES (2008)
In vitro susceptibility of Cryptococcus gattii clinical isolates
A. Gomez-Lopez et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Changing epidemiology of systemic fungal infections
M. Richardson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Candida parapsilosis, an Emerging Fungal Pathogen
David Trofa et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Infections caused by Scedosporium spp.
Karoll J. Cortez et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Therapy and outcome of Candida glabrata versus Candida albicans bloodstream infection
Michael J. Klevay et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Histoplasmosis in HIV-infected patients in a Southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy
John W. Baddley et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2008)
Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy
Nabil Kabbara et al.
HAEMATOLOGICA (2008)
Take control over your fluconazole prescriptions:: The growing importance of Candida glabrata as an agent of candidemia in Brazil
Alessandro C. Pasqualotto et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Secular Trends in Candidemia-Related Hospitalization in the United States, 2000-2005
Marya D. Zilberberg et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Molecular epidemiology of Candida parapsilosis sepsis from outbreak investigations in neonatal intensive care units
Errol Reiss et al.
INFECTION GENETICS AND EVOLUTION (2008)
Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods
Ana Alastruey-Izquierdo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin:: Analysis and proposal for interpretive MIC breakpoints
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis
Shawn R. Lockhart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis:: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex
Kerry O'Donnell et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
In vitro survey of triazole cross-resistance among more than 700 clinical isolates of Aspergillus species
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage
Graeme N. Forrest et al.
JOURNAL OF INFECTION (2008)
Epidemiology and clinical significance of Pneumocystis colonization
Alison Morris et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Coccidioidomycosis
James M. Parish et al.
MAYO CLINIC PROCEEDINGS (2008)
Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome
Bradley J. Atkinson et al.
MEDICAL MYCOLOGY (2008)
A man with changes in mental status after liver transplantation - Disseminated cryptococcosis with cryptococcal meningitis in a liver-allograft recipient
Jay A. Fishman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Vertical and horizontal transmission of Candida albicans in very low birth weight infants using DNA fingerprinting techniques
Joseph M. Bliss et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2008)
Invasive candidiasis in long-term patients at a multidisciplinary intensive care unit: Candida colonization index, risk factors, treatment and outcome
Christina Agvald-Ohman et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Paecilomyces lilacinus infection in a liver transplant patient:: case report and review of the literature
T. Van Schooneveld et al.
TRANSPLANT INFECTIOUS DISEASE (2008)
Candida krusei, a multidrug-resistant opportunistic fungal pathogen:: Geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Selection of a surrogate agent (fluconazole or voriconazole) for initial susceptibility testing of posaconazole against Candida spp.:: Results from a global Antifungal Surveillance Program
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates:: Correlation with outcome in solid organ transplant recipients with Cryptococcosis
Dimitrios P. Kontoyiannis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Bench-to-bedside review: Candida infections in the intensive care unit
Marie Mean et al.
CRITICAL CARE (2008)
Fusarium and Candida albicans biofilms on soft contact lenses: Model development, influence of lens type, and susceptibility to lens care solutions
Yoshifumi Imamura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: Six years of global surveillance
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Rare and Emerging Agents of Hyalohyphomycosis
Deanna A. Sutton
CURRENT FUNGAL INFECTION REPORTS (2008)
Medical progress: Infection in solid-organ transplant recipients
Jay A. Fishman
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Candida parapsilosis fungemia in neonates:: genotyping results suggest healthcare workers hands as source, and review of published studies
Eveline C. van Asbeck et al.
MYCOPATHOLOGIA (2007)
Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections
David L. Horn et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2007)
Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL
J. L. Foell et al.
PEDIATRIC BLOOD & CANCER (2007)
Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the infectious diseases society of America
L. Joseph Wheat et al.
CLINICAL INFECTIOUS DISEASES (2007)
Fusarium Infections in Immunocompromised Patients
Marcio Nucci et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Safety, tolerance, and efficacy of posaconazole therapy in patients with nonmeningeal disseminated or chronic pulmonary coccidioidomycosis
Antonino Catanzaro et al.
CLINICAL INFECTIOUS DISEASES (2007)
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
Michael D. Parkins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Posaconazole therapy for chronic refractory coccidioidomycosis
David A. Stevens et al.
CHEST (2007)
Invasive Candida species infection:: the importance of adequate empirical antifungal therapy
Darius Armstrong-James
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
A cluster of Candida krusei infections in a haematological unit
Timo Hautala et al.
BMC INFECTIOUS DISEASES (2007)
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines
Kevin W. Garey et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Phylogenetic diversity and microsphere array-based genotyping of human pathogenic fusaria, including isolates from the multistate contact lens - Associated US Keratitis outbreaks of 2005 and 2006
Kerry O'Donnell et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
The Emergence of Non-albicans Candida Species as Causes of Invasive Candidiasis and Candidemia
Jack D. Sobel
CURRENT FUNGAL INFECTION REPORTS (2007)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005:: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
A new Aspergillus fumigatus resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations
E. Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
To test or not to test:: A cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemias
Curtis D. Collins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Outcomes attributable to neonatal candidiasis
Theoklis E. Zaoutis et al.
CLINICAL INFECTIOUS DISEASES (2007)
Systemic histoplasmosis - A 15-year retrospective institutional review of 111 patients
Maha A. Assi et al.
MEDICINE (2007)
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients:: Interhuman transmission or a common environmental source?
Mark G. J. de Boer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Multiple-triazole-resistant aspergillosis
Paul E. Verweij et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting
L. Ostrosky-Zeichner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Salvage treatment of histoplasmosis with posaconazole
Angela Restrepo et al.
JOURNAL OF INFECTION (2007)
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia
Andrew F. Shorr et al.
CRITICAL CARE MEDICINE (2007)
Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific northwest of the United States
Sarah E. Kidd et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Cryptococcus neoformans in organ transplant recipients:: Impact of calcineurin-inhibitor agents on mortality
Nina Singh et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with vorieonazole and terbinafine
Sunil V. Bhat et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2007)
DNA and the classical way: Identification of medically important molds in the 21st century
S. Arunmozhi Balajee et al.
MEDICAL MYCOLOGY (2007)
Primary Pneumocystis infection in infants hospitalized with acute respiratory tract infection
Hans Henrik Larsen et al.
EMERGING INFECTIOUS DISEASES (2007)
Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA
Laura MacDougall et al.
EMERGING INFECTIOUS DISEASES (2007)
Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. tested by clinical and laboratory standards institute-recommended broth microdilution methods
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Clustering of invasive Aspergillus ustus eye infections in a tertiary care hospital: A molecular epidemiologic study of an uncommon species
M. A. Saracli et al.
MEDICAL MYCOLOGY (2007)
Nosocomial fungal infections: epidemiology, diagnosis, and treatment
Joshua Perlroth et al.
MEDICAL MYCOLOGY (2007)
Scedosporium infection in a tertiary care cancer center:: A review of 25 cases from 1989-2006
Gregory A. Lamaris et al.
CLINICAL INFECTIOUS DISEASES (2006)
Molecular identification of Trichosporon species
Juan Luis Rodriguez-Tudela et al.
CLINICAL INFECTIOUS DISEASES (2006)
Long-term outcome of AIDS-associated cryptococcosis in the era of combination antiretroviral therapy
Olivier Lortholary et al.
AIDS (2006)
Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen
Sergio M. Borgia et al.
MEDICAL MYCOLOGY (2006)
Chronic refractory phaeohyphomycosis: successful treatment with posaconazole
Laurie A. Proia et al.
MYCOSES (2006)
In vitro activity and synergism of amphotericin B, azoles and cationic antimicrobials against the emerging pathogen Trichoderma spp.
Christina Kratzer et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
New agents for the treatment of fungal infections: Clinical efficacy and gaps in coverage
Elias K. Spanakis et al.
CLINICAL INFECTIOUS DISEASES (2006)
Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: The role of fluconazole resistance and immune reconstitution
Tihana Bicanic et al.
CLINICAL INFECTIOUS DISEASES (2006)
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole:: Geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Candida rugosa, an emerging fungal pathogen with resistance to azoles:: Geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections
F. J. Pastor et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Pneumocystis pneumonia - a retrospective study 1991-2001 in Gothenburg, Sweden
Laila Mikaelsson et al.
JOURNAL OF INFECTION (2006)
Biofilm formation by the emerging fungal pathogen Trichosporon asahii:: Development, architecture, and antifungal resistance
Giovanni Di Bonaventura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
American histoplasmosis in developing countries with a special focus on patients with HIV:: diagnosis, treatment, and prognosis
Pierre Couppie et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital
Luciano W. Lunardi et al.
CLINICAL INFECTIOUS DISEASES (2006)
Endemic mycoses: Blastomycosis, histoplasmosis, and sporotrichosis
Carol A. Kauffman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Aspergillosis: Spectrum of disease, diagnosis, and treatment
Penelope D. Barnes et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution
Douglas C. Chang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Successful treatment of breakthrough Trichosporon asahii fungemia with voriconazole in a patient with acute myeloid leukemia
Noboru Asada et al.
CLINICAL INFECTIOUS DISEASES (2006)
Invasive fungal pathogens: Current epidemiological trends
Michael A. Pfaller et al.
CLINICAL INFECTIOUS DISEASES (2006)
Effects of caspofungin against Candida guilliermondii and Candida parapsilosis
Francesco Barchiesi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Contemporary tools for the diagnosis and management of invasive mycoses
Barbara D. Alexander et al.
CLINICAL INFECTIOUS DISEASES (2006)
Nosocomial aspergillosis in outbreak settings
R. -P. Vonberg et al.
JOURNAL OF HOSPITAL INFECTION (2006)
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs
S. T. Tay et al.
MYCOSES (2006)
Epidemiology of community-onset Candidemia in Connecticut and Maryland
Andre N. Sofair et al.
CLINICAL INFECTIOUS DISEASES (2006)
Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis
Gregory T. Siwek et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2006)
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
Kevin W. Garey et al.
CLINICAL INFECTIOUS DISEASES (2006)
Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole
LJ Wheat et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients:: A systematic review
T Eckmanns et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata
Anil A. Panackal et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Geographic distribution of human blastomycosis cases in Milwaukee, Wisconsin, USA: Association with urban watersheds
DJ Baumgardner et al.
MYCOPATHOLOGIA (2006)
Changing incidence of Candida bloodstream infections among NICU patients in the United States:: 1995-2004
SK Fridkin et al.
PEDIATRICS (2006)
Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections:: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003
Benito Almirante et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Excess risk of death from intensive care unit - Acquired nosocomial bloodstream infections: A reappraisal
M Garrouste-Orgeas et al.
CLINICAL INFECTIOUS DISEASES (2006)
Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2006)
Interpretive breakpoints for fluconazole and Candida revisited:: a blueprint for the future of antifungal susceptibility testing
MA Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2006)
Recurrent central nervous system blastomycosis in an immunocompetent child treated successfully with sequential liposomal amphotericin B and voriconazole
J Panicker et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome
BJ Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Phenotypic switching in Candida lusitaniae on copper sulfate indicator agar:: Association with amphotericin B resistance and filamentation
NS Miller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient
M Krogh-Madsen et al.
CLINICAL INFECTIOUS DISEASES (2006)
Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: A 1-year retrospective study of consecutive patients at French transplantation centers
C Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Breakthrough trichosporonosis in patients with hematologic malignancies receiving micafungin
K Matsue et al.
CLINICAL INFECTIOUS DISEASES (2006)
Hospitalizations for endemic mycoses: A population-based national study
JH Chu et al.
CLINICAL INFECTIOUS DISEASES (2006)
Candida krusei transmission among hematology patients resolved by adapted antifungal prophylaxis and infection control measures
MC Vos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Correlation of MIC with outcome for Candida species tested against voriconazole:: Analysis and proposal for interpretive breakpoints
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Rhodotorula mucilaginosa outbreak in neonatal intensive care unit:: microbiological features, clinical presentation, and analysis of related variables
R Perniola et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2006)
Invasive candidiasis in the intensive care unit
L Ostrosky-Zeichner et al.
CRITICAL CARE MEDICINE (2006)
Invasive Acremonium strictum infection in a bone marrow transplant recipient
S Miyakis et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
A bedside scoring system (Candida score'') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
C León et al.
CRITICAL CARE MEDICINE (2006)
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi
M Cuenca-Estrella et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Triazole cross-resistance among candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy
SS Magill et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Current treatment strategies for disseminated candidiasis
BJ Spellberg et al.
CLINICAL INFECTIOUS DISEASES (2006)
Posaconazole as salvage therapy for zygomycosis
RN Greenberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Invasive candidiasis
Peter G. Pappas
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Cryptococcosis
Methee Chayakulkeeree et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2006)
Pneumocystis and Trypanosoma cruzi: Nomenclature and typifications
S Redhead et al.
JOURNAL OF EUKARYOTIC MICROBIOLOGY (2006)
Cryptococcosis in human immunodeficiency virus-negative patients
S Kiertiburanakul et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2006)
Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans
A Perkins et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Antifungal susceptibility testing methods
MA Pfaller
CURRENT DRUG TARGETS (2005)
Results from the ARTEMIS DISK global antifungal surveillance study:: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Invasive Saccharomyces infection:: A comprehensive review
A Enache-Angoulvant et al.
CLINICAL INFECTIOUS DISEASES (2005)
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis
TE Zaoutis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation:: a 6-year retrospective study
N De Castro et al.
BONE MARROW TRANSPLANTATION (2005)
Cryptococcus gattii in AIDS patients, southern California
S Chaturvedi et al.
EMERGING INFECTIOUS DISEASES (2005)
Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis
Georgios Chamilos et al.
JOURNAL OF INFECTION (2005)
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak
JA Fraser et al.
NATURE (2005)
Coccidioidomycosis in persons infected with HIV type 1
NM Ampel
CLINICAL INFECTIOUS DISEASES (2005)
Susceptibility patterns and molecular identification of Trichosporon species
JL Rodriguez-Tudela et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Candida glabrata fungemia:: Experience in a tertiary care center
A Malani et al.
CLINICAL INFECTIOUS DISEASES (2005)
Comparative gene genealogies indicate that two clonal lineages of Cryptococcus gattii in British Columbia resemble strains from other geographical areas
SE Kidd et al.
EUKARYOTIC CELL (2005)
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazol
BD Alexander et al.
TRANSPLANTATION (2005)
Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center
AG Freifeld et al.
TRANSPLANT INFECTIOUS DISEASE (2005)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Disseminated histoplasmosis in persons with interferon-γ receptor 1 deficiency
CS Zerbe et al.
CLINICAL INFECTIOUS DISEASES (2005)
Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C
RP Singh et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2005)
In vitro susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species to itraconazole:: Global survey of 9,359 isolates tested by clinical and laboratory standards institute broth microdilution methods
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Pneumocystis:: not just pneumonia
JC Peterson et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp isolates
S Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Recurrent exposure to Histoplasma capsulatum in modern air-conditioned buildings
JP Luby et al.
CLINICAL INFECTIOUS DISEASES (2005)
Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study
J Gavalda et al.
CLINICAL INFECTIOUS DISEASES (2005)
In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula
C Serena et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit
E Sarvikiví et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance
J Morgan et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2005)
Saccharomyces cerevisiae fungemia:: An emerging infectious disease
P Muñoz et al.
CLINICAL INFECTIOUS DISEASES (2005)
Targeted gene disruption of the 14-α sterol demethylase (cyp51A) in Aspergillus fumigatus and its role in azole drug susceptibility
E Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004)
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Initial management of candidemia at an academic medical center: Evaluation of the IDSA guidelines
M Patel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2005)
Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials
NI Paphitou et al.
MEDICAL MYCOLOGY (2005)
Successful treatment of cerebral blastomycosis with voriconazole
M Bakleh et al.
CLINICAL INFECTIOUS DISEASES (2005)
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B -: Clearance with voriconazole
C Antachopoulos et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Differences in interactions between azole drugs related to modifications in the 14-α sterol dernethylase gene (cyp51A) of Aspergillus fumigatus
G Garcia-Effron et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Zygomycosis in a Tertiary-Care Cancer Center in the era of Aspergillus-active antifungal therapy:: A case-control observational study of 27 recent cases
DP Kontoyiannis et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Disseminated Scedosporium prolificans infection and survival of a child with acute lymphoblastic leukemia
M Whyte et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2005)
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies:: a retrospective multicenter study from Italy and review of the literature
C Girmenia et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Fungal infections in transplant recipients receiving alemtuzumab
DS Nath et al.
TRANSPLANTATION PROCEEDINGS (2005)
Aspergillus lentulus sp nov., a new sibling species of A-fumigatus
SA Balajee et al.
EUKARYOTIC CELL (2005)
Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review
A Gomez-Lopez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
High frequency of Candida parapsilosis on the hands of healthy hosts
LA Bonassoli et al.
JOURNAL OF HOSPITAL INFECTION (2005)
Pneumocystis jirovecii in general population
FJ Medrano et al.
EMERGING INFECTIOUS DISEASES (2005)
Coccidioidomycosis in patients with hematologic malignancies
JE Blair et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Pulmonary mycetoma caused by an atypical isolate of Paecilomyces species in an immunocompetent individual: case report and literature review of Paecilomyces lung infections
F Gutierrez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Saccharomyces boulardii induced sepsis: Successful therapy with voriconazole after treatment failure with fluconazole
O Burkhardt et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2005)
Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis
T Bicanic et al.
LANCET INFECTIOUS DISEASES (2005)
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma
J Chen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Invasive Candida species infections: a 5 year population-based assessment
KB Laupland et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: Clinical characteristics and impact of antifungal agent therapy on outcome
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2005)
Epidemiology and outcome of zygomycosis: A review of 929 reported cases
MM Roden et al.
CLINICAL INFECTIOUS DISEASES (2005)
Candida orthopsilosis and Candida metapsilosis spp. nov to replace Candida parapsilosis groups II and III
A Tavanti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Activities of available and investigational antifungal agents against Rhodotorula species
DJ Diekema et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazole
SV Balashov et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Coccidioidomycosis - A descriptive survey of a reemerging disease. Clinical characteristics and current controversies
NF Crum et al.
MEDICINE (2004)
Pulmonary histoplasmosis syndromes: Recognition, diagnosis, and management
LJ Wheat et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Pneumocystis jirovecii dihydropteroate synthase genotypes in immunocompetent infants and immunosuppressed adults, Amiens, France
A Totet et al.
EMERGING INFECTIOUS DISEASES (2004)
Coccidioidomycosis among workers at an archeological site, northeastern Utah
LR Petersen et al.
EMERGING INFECTIOUS DISEASES (2004)
Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program
RA Hajjeh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.
E Bouza et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Infections due to emerging and uncommon medically important fungal pathogens
TJ Walsh et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Twelve years of fluconazole in clinical practice:: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
MA Pfaller et al.
CLINICAL MICROBIOLOGY AND INFECTION (2004)
In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program
MA Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2004)
Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants
FM Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Histoplasmosis in pregnancy - Case series and report of transplacental transmission
SP Whitt et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Three-dimensional models of wild-type and mutated forms of cytochrome P450 14α-sterol demethylases from Aspergillus fumigatus and Candida albicans provide insights into posaconazole binding
L Xiao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-Rich antigen
R Bialek et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Case study:: Posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera
R Negroni et al.
CLINICAL INFECTIOUS DISEASES (2004)
Blastoschizomyces capitatus infection in patients with leukemia:: Report of 26 cases
R Martino et al.
CLINICAL INFECTIOUS DISEASES (2004)
Primary central nervous system phaeohyphomycosis: A review of 101 cases
SG Revankar et al.
CLINICAL INFECTIOUS DISEASES (2004)
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance
L Huang et al.
EMERGING INFECTIOUS DISEASES (2004)
Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital
TA Clark et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Emerging fungal diseases: the importance of the host
GW Procop et al.
CLINICS IN LABORATORY MEDICINE (2004)
Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole
A Imhof et al.
CLINICAL INFECTIOUS DISEASES (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Has the epidemiolgy of Nosocomial Candidemia changed?
L Puzniak et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Trichosporonosis in a tertiary care cancer center: Risk factors, changing spectrum and determinants of outcome
DP Kontoyiannis et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Infections due to Aspergillus terreus:: A multicenter retrospective analysis of 83 cases
WJ Steinbach et al.
CLINICAL INFECTIOUS DISEASES (2004)
Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia
F Roblot et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Vitro antifungal susceptibilities of uncommon basidiomycetous yeasts
C Serena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents:: A global assessment from the ARTEMIS antifungal surveillance program conducted in 2001 and 2002
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Substitutions at methionine 220 in the 14α-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs
E Mellado et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Histoplasmosis in a pediatric oncology center
EE Adderson
JOURNAL OF PEDIATRICS (2004)
Pneumocystis pneumonia
CF Thomas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Evaluation of the Etest method using Mueller-Hinton agar with glucose and methylene blue for determining amphotericin B MICs for 4,936 clinical isolates of Candida speciesLE
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
L Bergstrom et al.
ARTHRITIS AND RHEUMATISM (2004)
Successful use of voriconazole for treatment of Coccidioides meningitis
LA Proia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Candida parapsilosis characterization in an outbreak setting
DM Kuhn et al.
EMERGING INFECTIOUS DISEASES (2004)
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia
J Chandenier et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
AE Brouwer et al.
LANCET (2004)
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia
CR Stein et al.
EMERGING INFECTIOUS DISEASES (2004)
Strain typing methods and molecular epidemiology of Pneumocystis pneumonia
C Ben Beard et al.
EMERGING INFECTIOUS DISEASES (2004)
Rare and emerging opportunistic fungal pathogens:: Concern for resistance beyond Candida albicans and Aspergillus fumigatus
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Prophylaxis and treatment of invasive candidiasis in the intensive care setting
L Ostrosky-Zeichner
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2004)
Granulomatous infectious diseases associated with tumor necrosis factor antagonists
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Current epidemiology of Pneumocystis pneumonia
A Morris et al.
EMERGING INFECTIOUS DISEASES (2004)
Clinical case of endocarditis due to Trichosporon inkin and antifungal susceptibility profile of the organism
JM Ramos et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Fusarium infection in hematopoietic stem cell transplant recipients
M Nucci et al.
CLINICAL INFECTIOUS DISEASES (2004)
Epidemiology of Aspergillus terreus at a university hospital
JW Baddley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-α therapy
CA Hage et al.
CHEST (2003)
In vitro susceptibility testing of Geotrichum capitatum:: Comparison of the E-test, disk diffusion, and sensititre colorimetric methods in the NCCLS M27-A2 broth microdilution reference method
C Girmenia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism
M Cassone et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
L Ostrosky-Zeichner et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Candidemia in a tertiary care cancer center - In vitro susceptibility and its association with outcome of initial antifungal therapy
A Antoniadou et al.
MEDICINE (2003)
Recurrent catheter-related Rhodotorula rubra infection
V Lo Re et al.
CLINICAL MICROBIOLOGY AND INFECTION (2003)
Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi
DJ Diekema et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection
M Nucci et al.
CANCER (2003)
Opportunistic mycelial fungal infections in organ transplant recipients:: Emerging importance of non-Aspergillus mycelial fungi
S Husain et al.
CLINICAL INFECTIOUS DISEASES (2003)
Successful treatment of coccidioidal meningitis with voriconazole
KJ Cortez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery
IB Gosbell et al.
MYCOSES (2003)
Voriconazole treatment for less-common, emerging, or refractory fungal infections
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2003)
Variation in susceptibility of bloodstream isolates of candida glabrata to fluconazole according to patient age and geographic location
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole
AM Nascimento et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
The epidemiology of sepsis in the United States from 1979 through 2000
GS Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: Comparison of yeast-like and mycelial forms
T Nakai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Intramedullary histoplasmosis spinal cord abscess in a nonendemic region: Case report and review of the literature
JS Hott et al.
JOURNAL OF SPINAL DISORDERS & TECHNIQUES (2003)
Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients
AE Wakefield et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
The changing epidemiology of cryptococcosis: An update from population-based active surveillance in 2 large metropolitan areas, 1992-2000
SA Mirza et al.
CLINICAL INFECTIOUS DISEASES (2003)
Fungal infections in the recipients of solid organ transplantation
N Singh
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
A point mutation in the 14α-sterol demethylase gene cyp51A contributes to itraconazole resistance in Aspergillus fumigatus
TM Diaz-Guerra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Coccidioidomycosis
TM Chiller et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2003)
Successful treatment of Trichosporon mucoides infection with fluconazole in a heart and kidney transplant recipient
RE Nettles et al.
CLINICAL INFECTIOUS DISEASES (2003)
Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome p450 14α-demethylase
PA Mann et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Catheter-related sepsis due to Rhodotorula glutinis
PR Hsueh et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Multidrug-resistant Trichosporon asahii isolates are susceptible to voriconazole
R Falk et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Candida lusitaniae infections in the era of fluconazole availability
JL Hawkins et al.
CLINICAL INFECTIOUS DISEASES (2003)
Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study
ES Manoloff et al.
EMERGING INFECTIOUS DISEASES (2003)
Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients
N Singh et al.
CLINICAL INFECTIOUS DISEASES (2003)
Donor-related coccidioidomycosis in organ transplant recipients
PW Wright et al.
CLINICAL INFECTIOUS DISEASES (2003)
Attributable mortality of nosocomial candidemia, revisited
O Gudlaugsson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region
G Nevez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Disseminated trichosporonosis caused by Trichosporon loubieri
FM Marty et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Risk of fungemia due to Rhodotorula and antifungal susceptibility testing of Rhodotorula isolates
AK Zaas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient
ABA Teixeira et al.
MYCOPATHOLOGIA (2003)
Scedosporium species infections and treatments
WJ Steinbach et al.
JOURNAL OF CHEMOTHERAPY (2003)
Nosocomial cluster of Candida guillermondii fungemia in surgical patients
L Masala et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2003)
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors
KA Marr et al.
BLOOD (2002)
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients
WJ Olver et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma:: a case report
Y Myoken et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2002)
Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care
S Harbarth et al.
ARCHIVES OF SURGERY (2002)
Emerging and less common fungal pathogens
RV Fleming et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
Invasive infections due to Trichoderma species:: Report of 2 cases, findings of in vitro susceptibility testing, and review of the literature
T Chouaki et al.
CLINICAL INFECTIOUS DISEASES (2002)
In vitro susceptibilities of cerebrospinal fluid isolates of Cryptococcus neoformans collected during a ten-year period against fluconazole, voriconazole and posaconazole (SCH56592)
ST Yildiran et al.
MYCOSES (2002)
Candidemia at a tertiary-care hospital:: Epidemiology, treatment, clinical outcome and risk factors for death
A Viudes et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.:: Global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Acremonium strictum pulmonary infection in a leukemic patient successfully treated with posaconazole after failure of amphotericin B
R Herbrecht et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2002)
Cutaneous infection by Fusarium species in healthy and Immunocompromised hosts:: Implications for diagnosis and management
M Nucci et al.
CLINICAL INFECTIOUS DISEASES (2002)
Effects of nosocomial candidemia on outcomes of critically ill patients
SI Blot et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Voriconazole treatment of disseminated Paecilomyces infection in a patient with acquired immunodeficiency syndrome
CA Martin et al.
CLINICAL INFECTIOUS DISEASES (2002)
Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient
J Lee et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2002)
Guidelines for preventing opportunistic infections among HIV-infected persons - 2002 - Recommendations of the US Public Health Service and the Infectious Diseases Society of America
H Masur et al.
ANNALS OF INTERNAL MEDICINE (2002)
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999
WE Trick et al.
CLINICAL INFECTIOUS DISEASES (2002)
A new name (Pneumocystis jiroveci) for Pneumocystis from humans
JR Stringer et al.
EMERGING INFECTIOUS DISEASES (2002)
Hematogenous infections due to Candida parapsilosis:: changing trends in fungemic patients at a comprehensive cancer center during the last four decades
A Safdar et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Identification of the first isolates of Trichosporon asahii var. asahii from disseminated trichosporonosis in China
P Abliz et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis
R Herbrecht et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate
D Goodman et al.
CLINICAL INFECTIOUS DISEASES (2002)
Nationwide survey of in vitro activities of itraconazole and voriconazole against clinical Aspergillus fumigatus isolates cultured between 1945 and 1998
PE Verweij et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model
QN Sun et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit
A Lupetti et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Seven cases of fungemia with Saccharomyces boulardii in critically ill patients
T Lherm et al.
INTENSIVE CARE MEDICINE (2002)
Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates
S Arikan et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2002)
Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance
NB McClenny et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Morbidity and mortality in South African gold miners: Impact of untreated disease due to human immunodeficiency virus
EL Corbett et al.
CLINICAL INFECTIOUS DISEASES (2002)
In vitro antifungal susceptibilities of Trichosporon species
NI Paphitou et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients
KA Marr et al.
CLINICAL INFECTIOUS DISEASES (2002)
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
DJ Diekema et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Pathogenic Aspergillus species recovered from a hospital water system:: A 3-year prospective study
EJ Anaissie et al.
CLINICAL INFECTIOUS DISEASES (2002)
Disseminated phaeohyphomycosis: Review of an emerging mycosis
SG Revankar et al.
CLINICAL INFECTIOUS DISEASES (2002)
Azole cross-resistance in Aspergillus fumigatus
J Mosquera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Update on the epidemiology and transmission of Pneumocystis carinii
A Morris et al.
MICROBES AND INFECTION (2002)
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use
W Hope et al.
JOURNAL OF HOSPITAL INFECTION (2002)
The direct cost and incidence of systemic fungal infections
LS Wilson et al.
VALUE IN HEALTH (2002)
Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000
MA Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital
WB Grow et al.
BONE MARROW TRANSPLANTATION (2002)
Pneumocystis carinii
AE Wakefield
BRITISH MEDICAL BULLETIN (2002)
Molecular and phenotypic description of Coccidioides Posadasii sp nov., previously recognized as the non-California population of Coccidioides immitis
MC Fisher et al.
MYCOLOGIA (2002)
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units
DG Wolf et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome
LJ Wheat et al.
CLINICAL INFECTIOUS DISEASES (2001)
The impact of culture isolation of Aspergillus species:: A hospital-based survey of aspergillosis
JR Perfect et al.
CLINICAL INFECTIOUS DISEASES (2001)
Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions
P Mwaba et al.
POSTGRADUATE MEDICAL JOURNAL (2001)
New insights into transmission, diagnosis, and drug treatment of Pneumocystis carinii pneumonia
JA Kovacs et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Risk factors for Candida tropicalis fungemia in patients with cancer
DP Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2001)
Trends in antifungal drug susceptibility of Cryptococcus neoformans isolates in the United States:: 1992 to 1994 and 1996 to 1998
ME Brandt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Pneumocystis carinii f. sp hominis DNA in immunocompetent health care workers in contact with patients with P-carinii pneumonia
RF Miller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
PG Pappas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Fungal infections in older adults
CA Kauffman
CLINICAL INFECTIOUS DISEASES (2001)
Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
HM Blumberg et al.
CLINICAL INFECTIOUS DISEASES (2001)
Invasive mold infections in allogeneic bone marrow transplant recipients
JW Baddley et al.
CLINICAL INFECTIOUS DISEASES (2001)
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons
RA Hajjeh et al.
CLINICAL INFECTIOUS DISEASES (2001)
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans
T Boekhout et al.
MICROBIOLOGY-UK (2001)
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients
RK Pelz et al.
ANNALS OF SURGERY (2001)
Estimating the cost of nosocomial candidemia in the United States
LG Miller et al.
CLINICAL INFECTIOUS DISEASES (2001)
Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants
SL Vargas et al.
CLINICAL INFECTIOUS DISEASES (2001)
Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a University Hospital
JW Braddley et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2001)
Efficacy of voriconazole in treatment of murine pulmonary blastomycosis
AM Sugar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Rhodotorula septicemia: case report and minireview
V Petrocheilou-Paschou et al.
CLINICAL MICROBIOLOGY AND INFECTION (2001)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Candida lusitaniae:: A cause of breakthrough fungemia in cancer patients
A Minari et al.
CLINICAL INFECTIOUS DISEASES (2001)
Case Report. Disseminated infection of Blastoschizomyces capitatus in a patient with acute myelocytic leukaemia
V Buchta et al.
MYCOSES (2001)
Studies on the molecular ecology of Blastomyces dermatitidis
DJ Baumgardner et al.
MYCOPATHOLOGIA (2001)
Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients
M Laverdière et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Burden of aspergillosis-related hospitalizations in the United States
EJ Dasbach et al.
CLINICAL INFECTIOUS DISEASES (2000)
Pathogenic roles for fungal melanins
ES Jacobson
CLINICAL MICROBIOLOGY REVIEWS (2000)
Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice
P Connolly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Trichosporon beigelii infection:: experience in a regional burn center
MJ Cawley et al.
BURNS (2000)
Fungal colonization of haematological patients receiving cytotoxic chemotherapy:: emergence of azole-resistant Saccharomyces cerevisiae
JH Salonen et al.
JOURNAL OF HOSPITAL INFECTION (2000)
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting
EH Ibrahim et al.
CHEST (2000)
Saccharomyces fungemia complicating Saccharomyces boulardii treatment in a nonimmunocompromised host
BJA Rijnders et al.
INTENSIVE CARE MEDICINE (2000)
In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis and Histoplasma capsulatum
RK Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?
M Goldman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Practice guidelines for the management of patients with histoplasmosis
J Wheat et al.
CLINICAL INFECTIOUS DISEASES (2000)
Genetic variation in Pneumocystis carinii isolates from different geographic regions:: Implications for transmission
CB Beard et al.
EMERGING INFECTIOUS DISEASES (2000)
Practice guidelines for the management of cryptococcal disease
MS Saag et al.
CLINICAL INFECTIOUS DISEASES (2000)
Risk factors for candidemia in neonatal intensive care unit patients
L Saiman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Epidemiology of human immunodeficiency virus-associated opportunistic infect-ions in the United States in the era of highly active antiretroviral therapy
JE Kaplan et al.
CLINICAL INFECTIOUS DISEASES (2000)
Trichosporon beigelii:: a life-threatening pathogen in immunocompromised hosts
B Erer et al.
BONE MARROW TRANSPLANTATION (2000)
Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Possible role of catheters in Saccharomyces boulardii fungemia
C Hennequin et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2000)
Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants
C Lass-Florl et al.
JOURNAL OF HOSPITAL INFECTION (2000)
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis
JR Graybill et al.
CLINICAL INFECTIOUS DISEASES (2000)
Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit
P Munoz et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: Case report and literature review of central nervous system pseudallescheriasis
MA Nesky et al.
CLINICAL INFECTIOUS DISEASES (2000)
Share Paper
